Althea is monitoring the coronavirus situation carefully and we are doing everything we can to help reduce the spread of the Covid-19 disease. We continue to supply our…
read more
Althea is pleased to advise that the UK Department of Health and Social Care and Home Office (Home Office) have announced that, following the relaxation of import…
read more2019 was a fantastic year of patient growth for Althea and on the back of the unrelenting efforts from our sales team, we successfully surpassed our target of 4,000…
read moreAlthea Partners with UK Scientific Drug Committee to Further Education on Medicinal Cannabis and Improve Patient Access. Article Highlights: Althea collaborates…
read moreAlthea is dedicated to supporting healthcare providers seeking information about and access to medicinal cannabis as a treatment option for eligible patients. One of the ways we connect with healthcare providers is by attending conferences and arranging education events.
View More Events
The growth continues! Althea has officially reached over 5,000 patients. This is an exciting milestone and a great reflection of the relentless hard work from all of the team. Thank you to all our fantastic partners and we look forward to further continued growth in 2020. https://t.co/itYfbPQHZn
read moreOur CEO Josh Fegan sat down with @CommSec's Tom Piotrowski to discuss our focus on education & technology to improve patient access to medicinal cannabis & the positive regulatory outlook for new jurisdictions & emerging markets | Video: http://ow.ly/BTEj50v0x8C
read moreAlthea is thrilled to announce that we will supply the first UK national medical cannabis pilot targeting 20,000 patients | Read the ASX announcement here: https://www.asx.com.au/asxpdf/20190625/pdf/4462xcgx974f62.pdf $AGH
read more
©2020 Althea Company Pty Ltd
